The Bio/Med Investor Network formally launched in Atlanta, Georgia.
Formed in late 2014, the Network, supported by Georgia Bio, the Georgia Research Alliance and each of the state’s research universities, includes about 40 accredited angel investors.
It will focus on early-stage investments in bioscience, medical technologies and digital health companies.
Investment targets will include Georgia-based companies typically seeking between $200k and $2M, with the network also evaluating investment opportunities throughout the United States.
FinSMEs
09/02/2015